imiquimod has been researched along with Agranulocytosis in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Becker, M; Bopp, T; Heib, V; Klein, M; Rechtsteiner, G; Schild, H; Schmitt, E; Stassen, M; Taube, C; Tertilt, C; Warger, T | 1 |
1 other study(ies) available for imiquimod and Agranulocytosis
Article | Year |
---|---|
Mast cells are crucial for early inflammation, migration of Langerhans cells, and CTL responses following topical application of TLR7 ligand in mice.
Topics: Adjuvants, Immunologic; Agranulocytosis; Aminoquinolines; Animals; Antigens; Cell Movement; Imiquimod; Immunity, Cellular; Immunity, Innate; Immunization; Immunoglobulin E; Inflammation; Interleukin-1beta; Langerhans Cells; Ligands; Mast Cells; Membrane Glycoproteins; Mice; Mice, Inbred BALB C; Skin; T-Lymphocytes, Cytotoxic; Toll-Like Receptor 7; Tumor Necrosis Factor-alpha; Vaccines | 2007 |